150 related articles for article (PubMed ID: 9122713)
1. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis.
Carmassi F; de Negri F; Morale M; Song KY; Chung SI
Semin Thromb Hemost; 1996; 22(6):489-96. PubMed ID: 9122713
[TBL] [Abstract][Full Text] [Related]
2. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
3. Factors that control extravascular fibrinolysis.
Chung SI; Lee SY; Uchino R; Carmassi F
Semin Thromb Hemost; 1996; 22(6):479-88. PubMed ID: 9122712
[TBL] [Abstract][Full Text] [Related]
4. Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid.
Clemmensen I; Andersen RB
J Lab Clin Med; 1978 Nov; 92(5):678-89. PubMed ID: 712203
[TBL] [Abstract][Full Text] [Related]
5. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways.
So AK; Varisco PA; Kemkes-Matthes B; Herkenne-Morard C; Chobaz-Péclat V; Gerster JC; Busso N
J Thromb Haemost; 2003 Dec; 1(12):2510-5. PubMed ID: 14675085
[TBL] [Abstract][Full Text] [Related]
6. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
Reed GL; Matsueda GR; Haber E
Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
[TBL] [Abstract][Full Text] [Related]
7. Fibrin clot formation and lysis: basic mechanisms.
Sidelmann JJ; Gram J; Jespersen J; Kluft C
Semin Thromb Hemost; 2000; 26(6):605-18. PubMed ID: 11140797
[TBL] [Abstract][Full Text] [Related]
8. [Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis].
Erov NK
Ter Arkh; 1986; 58(7):73-7. PubMed ID: 2945279
[TBL] [Abstract][Full Text] [Related]
9. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.
Mimuro J; Kimura S; Aoki N
J Clin Invest; 1986 Mar; 77(3):1006-13. PubMed ID: 2419360
[TBL] [Abstract][Full Text] [Related]
10. Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints.
Busso N; Dudler J; Salvi R; Péclat V; Lenain V; Marcovina S; Darioli R; Nicod P; So AK; Mooser V
Am J Pathol; 2001 Oct; 159(4):1445-53. PubMed ID: 11583972
[TBL] [Abstract][Full Text] [Related]
11. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
Wootton DM; Popel AS; Alevriadou BR
Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
[TBL] [Abstract][Full Text] [Related]
12. Fibrin dissolution in synovial fluid.
Andersen RB; Gormsen J
Acta Rheumatol Scand; 1970; 16(4):319-33. PubMed ID: 4099587
[No Abstract] [Full Text] [Related]
13. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
Bärtsch P; Haeberli A; Straub PW
Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
[TBL] [Abstract][Full Text] [Related]
14. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
15. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Weinberg JB; Pippen AM; Greenberg CS
Arthritis Rheum; 1991 Aug; 34(8):996-1005. PubMed ID: 1677574
[TBL] [Abstract][Full Text] [Related]
16. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Carroll RC; Lockhart MS; Taylor FB
J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
[TBL] [Abstract][Full Text] [Related]
17. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism.
Berckmans RJ; Nieuwland R; Tak PP; Böing AN; Romijn FP; Kraan MC; Breedveld FC; Hack CE; Sturk A
Arthritis Rheum; 2002 Nov; 46(11):2857-66. PubMed ID: 12428225
[TBL] [Abstract][Full Text] [Related]
18. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
19. Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage.
Furmaniak-Kazmierczak E; Cooke TD; Manuel R; Scudamore A; Hoogendorn H; Giles AR; Nesheim M
J Clin Invest; 1994 Aug; 94(2):472-80. PubMed ID: 8040300
[TBL] [Abstract][Full Text] [Related]
20. Degradation of cross-linked fibrin by human leukocyte proteases.
Francis CW; Marder VJ
J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
